Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DM9K6H5)

Drug Name
HAp-IFN Drug Info
Synonyms Hydroxyapatite-IFN (hepatitis C), LTT Bio-Pharma
Indication
Disease Entry ICD 11 Status REF
Hepatitis C virus infection 1E51.1 Investigative [1]
Cross-matching ID
TTD Drug ID
DM9K6H5

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Interferon-alpha 2 (IFNA2) TTSIUJ9 IFNA2_HUMAN Modulator [2]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Interferon-alpha 2 (IFNA2) DTT IFNA2 2.609 1.678 0.263 0.379
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Hepatitis C virus infection
ICD Disease Classification 1E51.1
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Interferon-alpha 2 (IFNA2) DTT IFNA2 9.31E-04 0.35 2.05
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032074)
2 CN patent application no. 1921880, Protein drug sustained-release microparticle preparation for injection and process for producing the same.